Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-12-13 Option Award | 2022-12-15 6:19 pm | N/A 2032-12-13 | Solid Biosciences Inc. | SLDB | Koppel Adam Director 10% Owner | 9,650 | $0 | 9,650 (Direct) | View |
| 2022-12-02 Option Award | 2022-12-05 5:16 pm | N/A 2032-12-01 | Solid Biosciences Inc. | SLDB | Koppel Adam Director 10% Owner | 2,666 | $0 | 2,666 (Direct) | View |
| 2022-12-02 Ownership | 2022-12-05 4:58 pm | N/A N/A | Solid Biosciences Inc. | SLDB | Koppel Adam Director 10% Owner | 0 | $0 | 3,130,423 (Indirect) | View |
| 2022-06-21 Option Award | 2022-06-22 8:59 pm | 2023-06-21 2032-06-20 | Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 5:10 pm | N/A 2032-06-14 | Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner | 23,459 | $0 | 23,459 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 5:06 pm | N/A 2032-05-25 | Aptinyx Inc. | APTX | Koppel Adam Director 10% Owner | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-12-28 Disposition | 2021-12-29 4:43 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Koppel Adam Director | 133,333 | $0 | 0 (Direct) | View |
| 2021-12-28 Equity Swap | 2021-12-29 4:43 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Koppel Adam Director | 3,083,570 | $38.25 | 0 (Direct) | View |
| 2021-07-19 Conversion | 2021-07-21 4:40 pm | N/A N/A | RAPID MICRO BIOSYSTEMS Inc | RPID | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner | 50,007,380 | $0 | 8,434,560 (Indirect) | View |
| 2021-07-14 Ownership | 2021-07-14 8:02 pm | N/A N/A | RAPID MICRO BIOSYSTEMS Inc | RPID | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner | 0 | $0 | 8,334,560 (Indirect) | View |
| 2021-07-13 Option Award | 2021-07-14 4:53 pm | 2022-07-13 2031-07-12 | Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director | 12,530 | $0 | 12,530 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-21 5:15 pm | N/A 2031-06-16 | Solid Biosciences Inc. | SLDB | Koppel Adam Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 8:25 pm | N/A 2031-06-10 | Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner | 42,950 | $0 | 42,950 (Direct) | View |
| 2021-06-03 Exercise | 2021-06-07 6:50 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Koppel Adam Director | 3,333 | $0 | 3,101,903 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-07 6:50 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Koppel Adam Director | 18,333 | $0 | 3,101,903 (Direct) | View |
| 2021-05-27 Option Award | 2021-06-01 4:30 pm | N/A 2031-05-26 | Aptinyx Inc. | APTX | Koppel Adam Director 10% Owner | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-03-23 Option Award | 2021-03-25 4:30 pm | N/A N/A | Solid Biosciences Inc. | SLDB | Koppel Adam Director | 869,565 | $5.75 | 7,929,918 (Indirect) | View |
| 2020-12-31 Option Award | 2021-01-05 4:44 pm | N/A 2030-12-30 | Aptinyx Inc. | APTX | Koppel Adam Director 10% Owner | 5,508 | $2.224 | 5,508 (Direct) | View |
| 2020-12-10 Option Award | 2020-12-11 4:30 pm | N/A N/A | Solid Biosciences Inc. | SLDB | Koppel Adam Director | 3,189,189 | $3.7 | 7,060,353 (Indirect) | View |
| 2020-10-27 Other | 2020-10-29 8:00 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner | 49,961,943 | $0 | 110,262,006 (Indirect) | View |
| 2020-10-27 Ownership | 2020-10-29 7:45 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director | 0 | $0 | 338,120 (Indirect) | View |
| 2020-10-26 Option Award | 2020-10-26 4:30 pm | N/A N/A | BCLS Acquisition Corp. | BLSA | Koppel Adam Director 10% Owner | 487,500 | $10 | 487,500 (Indirect) | View |
| 2020-10-22 Ownership | 2020-10-22 9:03 pm | N/A 2028-01-30 | Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director | 0 | $0 | 94,594 (Direct) | View |
| 2020-10-21 Ownership | 2020-10-21 8:05 pm | N/A N/A | BCLS Acquisition Corp. | BLSA | Koppel Adam Director 10% Owner | 0 | $0 | 3,503,750 (Indirect) | View |
| 2020-09-30 Option Award | 2020-10-02 4:15 pm | N/A 2030-09-29 | Aptinyx Inc. | APTX | Koppel Adam Director 10% Owner | 5,663 | $2.163 | 5,663 (Direct) | View |
| 2020-07-28 Conversion | 2020-07-28 4:45 pm | N/A N/A | Annexon Inc. | ANNX | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Koppel Adam Bain Capital Life Sciences Partners LP Schwartz Jeffrey Lawrence 10% Owner | 27,876,392 | $0 | 3,241,628 (Indirect) | View |
| 2020-07-23 Ownership | 2020-07-23 5:06 pm | N/A N/A | Annexon Inc. | ANNX | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Koppel Adam Schwartz Jeffrey Lawrence 10% Owner | 0 | $0 | 25,034,764 (Indirect) | View |
| 2020-06-30 Option Award | 2020-07-02 4:06 pm | N/A 2030-06-29 | Aptinyx Inc. | APTX | Koppel Adam Director 10% Owner | 4,370 | $2.677 | 4,370 (Direct) | View |
| 2020-06-16 Option Award | 2020-06-18 5:00 pm | N/A 2030-06-16 | Solid Biosciences Inc. | SLDB | Koppel Adam Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-16 8:09 pm | N/A N/A | Dicerna Pharmaceuticals Inc | DRNA | Koppel Adam Director | 18,333 | $0 | 18,333 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:15 pm | N/A 2030-05-19 | Aptinyx Inc. | APTX | Koppel Adam Director 10% Owner | 40,000 | $0 | 40,000 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 4:58 pm | N/A 2030-03-30 | Aptinyx Inc. | APTX | Koppel Adam Director 10% Owner | 8,296 | $1.356 | 8,296 (Direct) | View |
| 2020-02-04 Conversion | 2020-02-06 4:26 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Koppel Adam Schwartz Jeffrey Lawrence 10% Owner | 3,685,175 | $0 | 3,979,292 (Indirect) | View |
| 2020-01-30 Ownership | 2020-01-30 8:08 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Koppel Adam Schwartz Jeffrey Lawrence 10% Owner | 0 | $0 | 3,685,175 (Indirect) | View |